APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

IL-6 Receptor Antagonist

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global IL-6 Receptor Antagonist Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174001690327 December 2025196 pages

Choose your research edition.

Industry ResearchIL-6 Receptor Antagonist Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal IL-6 Receptor Antagonist Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal IL-6 Receptor Antagonist Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal IL-6 Receptor Antagonist Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal IL-6 Receptor Antagonist Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global IL-6 Receptor Antagonist market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for IL-6 Receptor Antagonist is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for IL-6 Receptor Antagonist is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for IL-6 Receptor Antagonist is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for IL-6 Receptor Antagonist is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of IL-6 Receptor Antagonist include Biogen, EUSA Pharma, Fresenius Kabi, Hetero, Janssen Biotech, Regeneron Pharmaceuticals, Roche, R-Pharm and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global IL-6 Receptor Antagonist market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of IL-6 Receptor Antagonist and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents IL-6 Receptor Antagonist sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the IL-6 Receptor Antagonist market size, projected growth trends, production technologies, key applications, and end-use industries.

IL-6 Receptor Antagonist Segment by Company

Biogen

EUSA Pharma

Fresenius Kabi

Hetero

Janssen Biotech

Regeneron Pharmaceuticals

Roche

R-Pharm

Sanofi

Bio-Thera Solutions

BeiGene

Hangzhou Bozhirui Biopharmaceutical

Zhuhai Livzon Biotechnology

IL-6 Receptor Antagonist Segment by Type

Tocilizumab

Siltuximab

Sarilumab

Satralizumab

Olokizumab

Other

IL-6 Receptor Antagonist Segment by Application

Systemic Juvenile Idiopathic Arthritis

Rheumatoid Arthritis

Giant Cell Arteritis

Other

IL-6 Receptor Antagonist Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global IL-6 Receptor Antagonist market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of IL-6 Receptor Antagonist and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of IL-6 Receptor Antagonist.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the IL-6 Receptor Antagonist market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of IL-6 Receptor Antagonist manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of IL-6 Receptor Antagonist in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of IL-6 Receptor Antagonist in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. IL-6 Receptor Antagonist Industry Trends Table 2. IL-6 Receptor Antagonist Industry Drivers Table 3. IL-6 Receptor Antagonist Industry Opportunities and Challenges Table 4. IL-6 Receptor Antagonist Industry Restraints Table 5. Global IL-6 Receptor Antagonist Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global IL-6 Receptor Antagonist Revenue Market Share by Manufacturers (2021-2026) Table 7. Global IL-6 Receptor Antagonist Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global IL-6 Receptor Antagonist Sales Market Share by Manufacturers Table 9. Global IL-6 Receptor Antagonist Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global IL-6 Receptor Antagonist Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global IL-6 Receptor Antagonist Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global IL-6 Receptor Antagonist Manufacturers, Product Type & Application Table 13. Global IL-6 Receptor Antagonist Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global IL-6 Receptor Antagonist by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tocilizumab Table 17. Major Manufacturers of Siltuximab Table 18. Major Manufacturers of Sarilumab Table 19. Major Manufacturers of Satralizumab Table 20. Major Manufacturers of Olokizumab Table 21. Major Manufacturers of Other Table 22. Global IL-6 Receptor Antagonist Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global IL-6 Receptor Antagonist Sales by Type (2021-2026) & (K Units) Table 24. Global IL-6 Receptor Antagonist Sales by Type (2027-2032) & (K Units) Table 25. Global IL-6 Receptor Antagonist Sales Market Share by Type (2021-2026) Table 26. Global IL-6 Receptor Antagonist Sales Market Share by Type (2027-2032) Table 27. Global IL-6 Receptor Antagonist Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 28. Global IL-6 Receptor Antagonist Revenue by Type (2021-2026) & (K Units) Table 29. Global IL-6 Receptor Antagonist Revenue by Type (2027-2032) & (K Units) Table 30. Global IL-6 Receptor Antagonist Revenue Market Share by Type (2021-2026) Table 31. Global IL-6 Receptor Antagonist Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Systemic Juvenile Idiopathic Arthritis Table 33. Major Manufacturers of Rheumatoid Arthritis Table 34. Major Manufacturers of Giant Cell Arteritis Table 35. Major Manufacturers of Other Table 36. Global IL-6 Receptor Antagonist Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global IL-6 Receptor Antagonist Sales by Application (2021-2026) & (K Units) Table 38. Global IL-6 Receptor Antagonist Sales by Application (2027-2032) & (K Units) Table 39. Global IL-6 Receptor Antagonist Sales Market Share by Application (2021-2026) Table 40. Global IL-6 Receptor Antagonist Sales Market Share by Application (2027-2032) Table 41. Global IL-6 Receptor Antagonist Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 42. Global IL-6 Receptor Antagonist Revenue by Application (2021-2026) & (K Units) Table 43. Global IL-6 Receptor Antagonist Revenue by Application (2027-2032) & (K Units) Table 44. Global IL-6 Receptor Antagonist Revenue Market Share by Application (2021-2026) Table 45. Global IL-6 Receptor Antagonist Revenue Market Share by Application (2027-2032) Table 46. Global IL-6 Receptor Antagonist Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global IL-6 Receptor Antagonist Sales by Region (2021-2026) & (K Units) Table 48. Global IL-6 Receptor Antagonist Sales Market Share by Region (2021-2026) Table 49. Global IL-6 Receptor Antagonist Sales Forecasted by Region (2027-2032) & (K Units) Table 50. Global IL-6 Receptor Antagonist Sales Forecasted Market Share by Region (2027-2032) Table 51. North America IL-6 Receptor Antagonist Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. North America IL-6 Receptor Antagonist Sales by Country (2021-2026) & (K Units) Table 53. North America IL-6 Receptor Antagonist Sales by Country (2027-2032) & (K Units) Table 54. Europe IL-6 Receptor Antagonist Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Europe IL-6 Receptor Antagonist Sales by Country (2021-2026) & (K Units) Table 56. Europe IL-6 Receptor Antagonist Sales by Country (2027-2032) & (K Units) Table 57. Asia Pacific IL-6 Receptor Antagonist Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Asia Pacific IL-6 Receptor Antagonist Sales by Country (2021-2026) & (K Units) Table 59. Asia Pacific IL-6 Receptor Antagonist Sales by Country (2027-2032) & (K Units) Table 60. South America, Middle East and Africa IL-6 Receptor Antagonist Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 61. South America, Middle East and Africa IL-6 Receptor Antagonist Sales by Country (2021-2026) & (K Units) Table 62. South America, Middle East and Africa IL-6 Receptor Antagonist Sales by Country (2027-2032) & (K Units) Table 63. Global IL-6 Receptor Antagonist Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global IL-6 Receptor Antagonist Revenue by Region (2021-2026) & (US$ Million) Table 65. Global IL-6 Receptor Antagonist Revenue by Region (2027-2032) & (US$ Million) Table 66. Global IL-6 Receptor Antagonist Revenue Market Share by Region (2021-2026) Table 67. Global IL-6 Receptor Antagonist Revenue Market Share by Region (2027-2032) Table 68. Biogen Company Information Table 69. Biogen Business Overview Table 70. Biogen IL-6 Receptor Antagonist Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Biogen IL-6 Receptor Antagonist Product Portfolio Table 72. Biogen Recent Development Table 73. EUSA Pharma Company Information Table 74. EUSA Pharma Business Overview Table 75. EUSA Pharma IL-6 Receptor Antagonist Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. EUSA Pharma IL-6 Receptor Antagonist Product Portfolio Table 77. EUSA Pharma Recent Development Table 78. Fresenius Kabi Company Information Table 79. Fresenius Kabi Business Overview Table 80. Fresenius Kabi IL-6 Receptor Antagonist Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Fresenius Kabi IL-6 Receptor Antagonist Product Portfolio Table 82. Fresenius Kabi Recent Development Table 83. Hetero Company Information Table 84. Hetero Business Overview Table 85. Hetero IL-6 Receptor Antagonist Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Hetero IL-6 Receptor Antagonist Product Portfolio Table 87. Hetero Recent Development Table 88. Janssen Biotech Company Information Table 89. Janssen Biotech Business Overview Table 90. Janssen Biotech IL-6 Receptor Antagonist Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Janssen Biotech IL-6 Receptor Antagonist Product Portfolio Table 92. Janssen Biotech Recent Development Table 93. Regeneron Pharmaceuticals Company Information Table 94. Regeneron Pharmaceuticals Business Overview Table 95. Regeneron Pharmaceuticals IL-6 Receptor Antagonist Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Regeneron Pharmaceuticals IL-6 Receptor Antagonist Product Portfolio Table 97. Regeneron Pharmaceuticals Recent Development Table 98. Roche Company Information Table 99. Roche Business Overview Table 100. Roche IL-6 Receptor Antagonist Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Roche IL-6 Receptor Antagonist Product Portfolio Table 102. Roche Recent Development Table 103. R-Pharm Company Information Table 104. R-Pharm Business Overview Table 105. R-Pharm IL-6 Receptor Antagonist Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. R-Pharm IL-6 Receptor Antagonist Product Portfolio Table 107. R-Pharm Recent Development Table 108. Sanofi Company Information Table 109. Sanofi Business Overview Table 110. Sanofi IL-6 Receptor Antagonist Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Sanofi IL-6 Receptor Antagonist Product Portfolio Table 112. Sanofi Recent Development Table 113. Bio-Thera Solutions Company Information Table 114. Bio-Thera Solutions Business Overview Table 115. Bio-Thera Solutions IL-6 Receptor Antagonist Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Bio-Thera Solutions IL-6 Receptor Antagonist Product Portfolio Table 117. Bio-Thera Solutions Recent Development Table 118. BeiGene Company Information Table 119. BeiGene Business Overview Table 120. BeiGene IL-6 Receptor Antagonist Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. BeiGene IL-6 Receptor Antagonist Product Portfolio Table 122. BeiGene Recent Development Table 123. Hangzhou Bozhirui Biopharmaceutical Company Information Table 124. Hangzhou Bozhirui Biopharmaceutical Business Overview Table 125. Hangzhou Bozhirui Biopharmaceutical IL-6 Receptor Antagonist Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Hangzhou Bozhirui Biopharmaceutical IL-6 Receptor Antagonist Product Portfolio Table 127. Hangzhou Bozhirui Biopharmaceutical Recent Development Table 128. Zhuhai Livzon Biotechnology Company Information Table 129. Zhuhai Livzon Biotechnology Business Overview Table 130. Zhuhai Livzon Biotechnology IL-6 Receptor Antagonist Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Zhuhai Livzon Biotechnology IL-6 Receptor Antagonist Product Portfolio Table 132. Zhuhai Livzon Biotechnology Recent Development Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. IL-6 Receptor Antagonist Distributors List Table 136. IL-6 Receptor Antagonist Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. IL-6 Receptor Antagonist Product Image Figure 2. Global IL-6 Receptor Antagonist Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global IL-6 Receptor Antagonist Market Size (2021-2032) & (US$ Million) Figure 4. Global IL-6 Receptor Antagonist Sales (2021-2032) & (K Units) Figure 5. Global IL-6 Receptor Antagonist Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 IL-6 Receptor Antagonist Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tocilizumab Image Figure 9. Siltuximab Image Figure 10. Sarilumab Image Figure 11. Satralizumab Image Figure 12. Olokizumab Image Figure 13. Other Image Figure 14. Global IL-6 Receptor Antagonist Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global IL-6 Receptor Antagonist Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global IL-6 Receptor Antagonist Sales Market Share by Type (2021-2032) Figure 17. Global IL-6 Receptor Antagonist Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 18. Global IL-6 Receptor Antagonist Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global IL-6 Receptor Antagonist Revenue Market Share by Type (2021-2032) Figure 20. Systemic Juvenile Idiopathic Arthritis Image Figure 21. Rheumatoid Arthritis Image Figure 22. Giant Cell Arteritis Image Figure 23. Other Image Figure 24. Global IL-6 Receptor Antagonist Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global IL-6 Receptor Antagonist Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global IL-6 Receptor Antagonist Sales Market Share by Application (2021-2032) Figure 27. Global IL-6 Receptor Antagonist Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global IL-6 Receptor Antagonist Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global IL-6 Receptor Antagonist Revenue Market Share by Application (2021-2032) Figure 30. North America IL-6 Receptor Antagonist Sales and Growth Rate (2021-2032) & (K Units) Figure 31. North America IL-6 Receptor Antagonist Sales Market Share by Country (2021-2032) Figure 32. U.S. IL-6 Receptor Antagonist Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Canada IL-6 Receptor Antagonist Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Mexico IL-6 Receptor Antagonist Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe IL-6 Receptor Antagonist Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Europe IL-6 Receptor Antagonist Sales Market Share by Country (2021-2032) Figure 37. Germany IL-6 Receptor Antagonist Sales and Growth Rate (2021-2032) & (K Units) Figure 38. France IL-6 Receptor Antagonist Sales and Growth Rate (2021-2032) & (K Units) Figure 39. U.K. IL-6 Receptor Antagonist Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Italy IL-6 Receptor Antagonist Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Netherlands IL-6 Receptor Antagonist Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific IL-6 Receptor Antagonist Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Asia Pacific IL-6 Receptor Antagonist Sales Market Share by Country (2021-2032) Figure 44. China IL-6 Receptor Antagonist Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Japan IL-6 Receptor Antagonist Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South Korea IL-6 Receptor Antagonist Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Southeast Asia IL-6 Receptor Antagonist Sales and Growth Rate (2021-2032) & (K Units) Figure 48. India IL-6 Receptor Antagonist Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Australia IL-6 Receptor Antagonist Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa IL-6 Receptor Antagonist Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South America, Middle East and Africa IL-6 Receptor Antagonist Sales Market Share by Country (2021-2032) Figure 52. Brazil IL-6 Receptor Antagonist Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South Africa IL-6 Receptor Antagonist Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Saudi Arabia IL-6 Receptor Antagonist Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Turkey IL-6 Receptor Antagonist Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Argentina IL-6 Receptor Antagonist Sales and Growth Rate (2021-2032) & (K Units) Figure 57. UAE IL-6 Receptor Antagonist Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Egypt IL-6 Receptor Antagonist Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Chile IL-6 Receptor Antagonist Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Global IL-6 Receptor Antagonist Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global IL-6 Receptor Antagonist Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America IL-6 Receptor Antagonist Revenue (2021-2032) & (US$ Million) Figure 63. North America IL-6 Receptor Antagonist Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe IL-6 Receptor Antagonist Revenue (2021-2032) & (US$ Million) Figure 65. Europe IL-6 Receptor Antagonist Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific IL-6 Receptor Antagonist Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific IL-6 Receptor Antagonist Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa IL-6 Receptor Antagonist Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa IL-6 Receptor Antagonist Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. IL-6 Receptor Antagonist Value Chain Figure 71. Manufacturing Cost Structure Figure 72. IL-6 Receptor Antagonist Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Tocilizumab
  • Siltuximab
  • Sarilumab
  • Satralizumab
  • Olokizumab
  • Other
Applications
  • Systemic Juvenile Idiopathic Arthritis
  • Rheumatoid Arthritis
  • Giant Cell Arteritis
  • Other
Companies covered
  • Biogen
  • EUSA Pharma
  • Fresenius Kabi
  • Hetero
  • Janssen Biotech
  • Regeneron Pharmaceuticals
  • Roche
  • R-Pharm
  • Sanofi
  • Bio-Thera Solutions
  • BeiGene
  • Hangzhou Bozhirui Biopharmaceutical
  • Zhuhai Livzon Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global IL-6 Receptor Antagonist Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global IL-6 Receptor Antagonist Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global IL-6 Receptor Antagonist Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global IL-6 Receptor Antagonist Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global IL-6 Receptor Antagonist Market Dynamics
  1. 2.1 IL-6 Receptor Antagonist Industry Trends
  2. 2.2 IL-6 Receptor Antagonist Industry Drivers
  3. 2.3 IL-6 Receptor Antagonist Industry Opportunities and Challenges
  4. 2.4 IL-6 Receptor Antagonist Industry Restraints
3 IL-6 Receptor Antagonist Market by Manufacturers
  1. 3.1 Global IL-6 Receptor Antagonist Revenue by Manufacturers (2021-2026)
  2. 3.2 Global IL-6 Receptor Antagonist Sales by Manufacturers (2021-2026)
  3. 3.3 Global IL-6 Receptor Antagonist Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global IL-6 Receptor Antagonist Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global IL-6 Receptor Antagonist Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global IL-6 Receptor Antagonist Manufacturers, Product Type & Application
  7. 3.7 Global IL-6 Receptor Antagonist Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global IL-6 Receptor Antagonist Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 IL-6 Receptor Antagonist Players Market Share by Revenue in 2025
  11. 3.8.3 2025 IL-6 Receptor Antagonist Tier 1, Tier 2, and Tier 3
4 IL-6 Receptor Antagonist Market by Type
  1. 4.1 IL-6 Receptor Antagonist Type Introduction
  2. 4.1.1 Tocilizumab
  3. 4.1.2 Siltuximab
  4. 4.1.3 Sarilumab
  5. 4.1.4 Satralizumab
  6. 4.1.5 Olokizumab
  7. 4.1.6 Other
  8. 4.2 Global IL-6 Receptor Antagonist Sales by Type
  9. 4.2.1 Global IL-6 Receptor Antagonist Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global IL-6 Receptor Antagonist Sales by Type (2021-2032)
  11. 4.2.3 Global IL-6 Receptor Antagonist Sales Market Share by Type (2021-2032)
  12. 4.3 Global IL-6 Receptor Antagonist Revenue by Type
  13. 4.3.1 Global IL-6 Receptor Antagonist Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global IL-6 Receptor Antagonist Revenue by Type (2021-2032)
  15. 4.3.3 Global IL-6 Receptor Antagonist Revenue Market Share by Type (2021-2032)
5 IL-6 Receptor Antagonist Market by Application
  1. 5.1 IL-6 Receptor Antagonist Application Introduction
  2. 5.1.1 Systemic Juvenile Idiopathic Arthritis
  3. 5.1.2 Rheumatoid Arthritis
  4. 5.1.3 Giant Cell Arteritis
  5. 5.1.4 Other
  6. 5.2 Global IL-6 Receptor Antagonist Sales by Application
  7. 5.2.1 Global IL-6 Receptor Antagonist Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global IL-6 Receptor Antagonist Sales by Application (2021-2032)
  9. 5.2.3 Global IL-6 Receptor Antagonist Sales Market Share by Application (2021-2032)
  10. 5.3 Global IL-6 Receptor Antagonist Revenue by Application
  11. 5.3.1 Global IL-6 Receptor Antagonist Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global IL-6 Receptor Antagonist Revenue by Application (2021-2032)
  13. 5.3.3 Global IL-6 Receptor Antagonist Revenue Market Share by Application (2021-2032)
6 Global IL-6 Receptor Antagonist Sales by Region
  1. 6.1 Global IL-6 Receptor Antagonist Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global IL-6 Receptor Antagonist Sales by Region (2021-2032)
  3. 6.2.1 Global IL-6 Receptor Antagonist Sales by Region (2021-2026)
  4. 6.2.2 Global IL-6 Receptor Antagonist Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America IL-6 Receptor Antagonist Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America IL-6 Receptor Antagonist Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe IL-6 Receptor Antagonist Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe IL-6 Receptor Antagonist Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific IL-6 Receptor Antagonist Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific IL-6 Receptor Antagonist Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa IL-6 Receptor Antagonist Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa IL-6 Receptor Antagonist Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global IL-6 Receptor Antagonist Revenue by Region
  1. 7.1 Global IL-6 Receptor Antagonist Revenue by Region
  2. 7.1.1 Global IL-6 Receptor Antagonist Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global IL-6 Receptor Antagonist Revenue by Region (2021-2026)
  4. 7.1.3 Global IL-6 Receptor Antagonist Revenue by Region (2027-2032)
  5. 7.1.4 Global IL-6 Receptor Antagonist Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America IL-6 Receptor Antagonist Revenue (2021-2032)
  8. 7.2.2 North America IL-6 Receptor Antagonist Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe IL-6 Receptor Antagonist Revenue (2021-2032)
  11. 7.3.2 Europe IL-6 Receptor Antagonist Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific IL-6 Receptor Antagonist Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific IL-6 Receptor Antagonist Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa IL-6 Receptor Antagonist Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa IL-6 Receptor Antagonist Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Biogen
  2. 8.1.1 Biogen Company Information
  3. 8.1.2 Biogen Business Overview
  4. 8.1.3 Biogen IL-6 Receptor Antagonist Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Biogen IL-6 Receptor Antagonist Product Portfolio
  6. 8.1.5 Biogen Recent Developments
  7. 8.2 EUSA Pharma
  8. 8.2.1 EUSA Pharma Company Information
  9. 8.2.2 EUSA Pharma Business Overview
  10. 8.2.3 EUSA Pharma IL-6 Receptor Antagonist Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 EUSA Pharma IL-6 Receptor Antagonist Product Portfolio
  12. 8.2.5 EUSA Pharma Recent Developments
  13. 8.3 Fresenius Kabi
  14. 8.3.1 Fresenius Kabi Company Information
  15. 8.3.2 Fresenius Kabi Business Overview
  16. 8.3.3 Fresenius Kabi IL-6 Receptor Antagonist Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Fresenius Kabi IL-6 Receptor Antagonist Product Portfolio
  18. 8.3.5 Fresenius Kabi Recent Developments
  19. 8.4 Hetero
  20. 8.4.1 Hetero Company Information
  21. 8.4.2 Hetero Business Overview
  22. 8.4.3 Hetero IL-6 Receptor Antagonist Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hetero IL-6 Receptor Antagonist Product Portfolio
  24. 8.4.5 Hetero Recent Developments
  25. 8.5 Janssen Biotech
  26. 8.5.1 Janssen Biotech Company Information
  27. 8.5.2 Janssen Biotech Business Overview
  28. 8.5.3 Janssen Biotech IL-6 Receptor Antagonist Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Janssen Biotech IL-6 Receptor Antagonist Product Portfolio
  30. 8.5.5 Janssen Biotech Recent Developments
  31. 8.6 Regeneron Pharmaceuticals
  32. 8.6.1 Regeneron Pharmaceuticals Company Information
  33. 8.6.2 Regeneron Pharmaceuticals Business Overview
  34. 8.6.3 Regeneron Pharmaceuticals IL-6 Receptor Antagonist Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Regeneron Pharmaceuticals IL-6 Receptor Antagonist Product Portfolio
  36. 8.6.5 Regeneron Pharmaceuticals Recent Developments
  37. 8.7 Roche
  38. 8.7.1 Roche Company Information
  39. 8.7.2 Roche Business Overview
  40. 8.7.3 Roche IL-6 Receptor Antagonist Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Roche IL-6 Receptor Antagonist Product Portfolio
  42. 8.7.5 Roche Recent Developments
  43. 8.8 R-Pharm
  44. 8.8.1 R-Pharm Company Information
  45. 8.8.2 R-Pharm Business Overview
  46. 8.8.3 R-Pharm IL-6 Receptor Antagonist Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 R-Pharm IL-6 Receptor Antagonist Product Portfolio
  48. 8.8.5 R-Pharm Recent Developments
  49. 8.9 Sanofi
  50. 8.9.1 Sanofi Company Information
  51. 8.9.2 Sanofi Business Overview
  52. 8.9.3 Sanofi IL-6 Receptor Antagonist Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sanofi IL-6 Receptor Antagonist Product Portfolio
  54. 8.9.5 Sanofi Recent Developments
  55. 8.10 Bio-Thera Solutions
  56. 8.10.1 Bio-Thera Solutions Company Information
  57. 8.10.2 Bio-Thera Solutions Business Overview
  58. 8.10.3 Bio-Thera Solutions IL-6 Receptor Antagonist Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Bio-Thera Solutions IL-6 Receptor Antagonist Product Portfolio
  60. 8.10.5 Bio-Thera Solutions Recent Developments
  61. 8.11 BeiGene
  62. 8.11.1 BeiGene Company Information
  63. 8.11.2 BeiGene Business Overview
  64. 8.11.3 BeiGene IL-6 Receptor Antagonist Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 BeiGene IL-6 Receptor Antagonist Product Portfolio
  66. 8.11.5 BeiGene Recent Developments
  67. 8.12 Hangzhou Bozhirui Biopharmaceutical
  68. 8.12.1 Hangzhou Bozhirui Biopharmaceutical Company Information
  69. 8.12.2 Hangzhou Bozhirui Biopharmaceutical Business Overview
  70. 8.12.3 Hangzhou Bozhirui Biopharmaceutical IL-6 Receptor Antagonist Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hangzhou Bozhirui Biopharmaceutical IL-6 Receptor Antagonist Product Portfolio
  72. 8.12.5 Hangzhou Bozhirui Biopharmaceutical Recent Developments
  73. 8.13 Zhuhai Livzon Biotechnology
  74. 8.13.1 Zhuhai Livzon Biotechnology Company Information
  75. 8.13.2 Zhuhai Livzon Biotechnology Business Overview
  76. 8.13.3 Zhuhai Livzon Biotechnology IL-6 Receptor Antagonist Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Zhuhai Livzon Biotechnology IL-6 Receptor Antagonist Product Portfolio
  78. 8.13.5 Zhuhai Livzon Biotechnology Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 IL-6 Receptor Antagonist Value Chain Analysis
  2. 9.1.1 IL-6 Receptor Antagonist Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 IL-6 Receptor Antagonist Production Mode & Process
  6. 9.2 IL-6 Receptor Antagonist Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 IL-6 Receptor Antagonist Distributors
  9. 9.2.3 IL-6 Receptor Antagonist Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst